


CellVax Therapeutics Email Formats
Biotechnology Research • Miami, Florida, United States • 1-10 Employees
CellVax Therapeutics Email Formats
CellVax Therapeutics uses 1 email format. The most common is {last name} (e.g., doe@cellvx.com), used 100% of the time.
| Format | Example | Percentage |
|---|---|---|
{last name} | doe@cellvx.com | 100% |
Key Contact at CellVax Therapeutics
Fernando Kreutz
CEO
Company overview
| Headquarters | 1951 NW 7th Ave, 3rd Floor | Suite 130, Miami, Florida 33136, US |
| Phone number | +12156428954 |
| Websites | |
| NAICS | 541714 |
| Keywords | Prostate Cancer, Immunotherapy, Solid Tumors, Cell-Based Therapy, Prostate Cancer Vaccine, Autologous Vaccine, Fk-Pc101, Mhc Ii |
| Founded | 2020 |
| Employees | 1-10 |
| Socials |
About CellVax Therapeutics
CellVax Therapeutics is a privately-held clinical-stage company active in research, development, and innovation on individualized cell-based immunotherapies. CellVax Therapeutics has developed a proprietary personalized tumor cell-based cancer immuno-therapy platform. The company has completed Phase I and Phase II clinical trial in Brazil and has initiated (Oct 24) a Phase II Adaptive Design Trial for patients with high-risk prostate cancer. https://clinicaltrials.gov/study/NCT06636682
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
CellVax Therapeutics has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
Explore CellVax Therapeutics's funding history, including investment rounds, total capital raised, and key backers.
CellVax Therapeutics Tech Stack
Discover the technologies and tools that power CellVax Therapeutics's digital infrastructure, from frameworks to analytics platforms.
Web servers
Frequently asked questions
4.8
40,000 users



